首页> 外文OA文献 >Cell Image-Based Informatics for Control of Cell-Based Therapeutic Product Manufacturing

【2h】

Cell Image-Based Informatics for Control of Cell-Based Therapeutic Product Manufacturing

机译：基于细胞图像的信息控制，用于控制细胞的治疗产品制造

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ryuji KATO;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Gaps between Asian regulations for eligibility of human mesenchymal stromal cells as starting materials of cell therapy products and comparability of mesenchymal stromal cell-based products subject to changes in their manufacturing process [J] . Toshimitsu Tanaka, Shing-Mou Lee, Mayu Mikami, Regenerative Therapy . 2020,第2期

机译：亚洲人间充质基质细胞作为细胞疗法原料和间充质基质细胞基产品的起始材料之间的差距，其制造工艺变化的间充质基质细胞的可比性
2. Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use [J] . Salmikangas Paula, Menezes-Ferreira Margarida, Reischl Ilona, Regenerative medicine . 2015,第1期

机译：基于细胞的药品的制造，表征和控制：面向商业用途的挑战性范式
3. Regulatory framework for CAR-T cells: how can french healthcare providers adapt their organization to requirements for manufacturing and delivery of these innovative cell-based medicinal products? [J] . Chabannon Christian, Larghero Jerome Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer . 2018,第Suppla2期

机译：Car-T细胞的监管框架：法国医疗保健提供者如何使其组织适应制造和交付这些基于细胞的药品的要求？
4. A simulation architecture with distributed controllers for cell-based manufacturing systems [C] . Hansoo Kim, Sug Je Sohn, Ying Wang, . 2002

机译：用于基于单元的制造系统的带有分布式控制器的仿真架构
5. MicroRNA-124-Loaded Nanoparticles as a New Promising Therapeutic Tool for Neural Stem Cell-Based Brain Repair Strategies [D] . Saraiva, Cláudia Marisa Monteiro 2017

机译：MicroRNA-124负载纳米粒子作为神经干细胞的脑修复策略的新有前途的治疗工具
6. Gaps between Asian regulations for eligibility of human mesenchymal stromal cells as starting materials of cell therapy products and comparability of mesenchymal stromal cell-based products subject to changes in their manufacturing process [O] . Toshimitsu Tanaka, Shing-Mou Lee, Mayu Mikami, 2020

机译：亚洲人间充质基质细胞作为细胞疗法原料和间充质基质细胞基产品的起始材料之间的差距其制造工艺变化的间充质基质细胞的可比性
7. Cell microfactories: manufacturing cell-based therapeutics FIRM abstract [O] . Harrison Richard P., Thurman-Newell Jamie A., Petzing Jon N., 2016

机译：细胞微工厂：制造基于细胞的疗法FIRM摘要

Cell Image-Based Informatics for Control of Cell-Based Therapeutic Product Manufacturing

著录项

引文网络

相似文献

相关主题

期刊订阅